Results 1 to 10 of about 131,281 (256)

Risk stratification scores for major bleeding in patients with venous thromboembolism

Spanish Journal of Medicine, 2021
The standard treatment for venous thromboembolism (VTE) is anticoagulation. Drug selection and treatment duration will depend on the clinical presentation, the existence of provoking factors, bleeding risk, and the patient’s preferences.
Francisco Galeano-Valle, Lucía Ordieres-Ortega, Pablo Demelo-Rodríguez   +2 more
doaj   +1 more source

Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable?

TH Open, 2021
Introduction Dose adjustment based on laboratory monitoring is not routinely recommended for patients treated with rivaroxaban but because an association has been reported between high drug level and bleeding, it would be of interest to know if measuring
Krishnan Shyamkumar, Jack Hirsh, Vinai C. Bhagirath, Jeffrey S. Ginsberg, John W. Eikelboom, Noel C. Chan   +5 more
doaj   +1 more source

A rare case of stroke as a complication after percutaneous mechanical thrombectomy in a patient with intermediate-high risk pulmonary embolism and patent foramen ovale

European Journal of Case Reports in Internal Medicine, 2023
We present an extremely rare case of a patient with intermediate-high risk pulmonary embolism treated with percutaneous mechanical thrombectomy, complicated with stroke as a form of paradoxical embolism through a previously unknown patent foramen ovale ...
Marina López-Rubio, Aurora Gómez-Tórtola, Iago Sousa-Casasnovas, Jorge García-Carreño, Marta Vales-Montero, Crhistian Mario Oblitas, Pablo Demelo-Rodríguez, Francisco Galeano-Valle   +7 more
doaj   +1 more source

Tranexamic Acid Administered During Off-Pump Coronary Artery Bypass Graft Surgeries Achieves Good Safety Effects and Hemostasis

Frontiers in Cardiovascular Medicine, 2022
BackgroundTranexamic acid (TXA) administered during off-pump coronary artery bypass (OPCAB) surgeries has achieved good blood control in small cohorts.
Enshi Wang, Xin Yuan, Yang Wang, Weinan Chen, Xingtong Zhou, Shengshou Hu, Su Yuan   +6 more
doaj   +1 more source

A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension [PDF]

, 2021
Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by recurrent or unresolved pulmonary thromboemboli, leading to perfusion defects and increased arterial wave reflections. CTEPH treatment aims to reduce pulmonary arterial pressure and reestablish adequate lung perfusion, yet patients with distal lesions are inoperable by standard surgical
arxiv   +1 more source

Clinical manual for diagnosis, prevention and treatment of cardiovascular complications of cancer therapy. Parts VI-VII [PDF]

Системные гипертензии, 2018
Advances in treatment have led to improved survival of patients with cancer but have also resulted in untoward side effects associated with treatment. Cardiovascular diseases are one of the most frequent of these side effects.
I Ye Chazova, S A Tyulyandin, M V Vitsenia, E P Panchenko, Yu A Fedotkina, M G Poltavskaya, M Yu Gilyarov, T V Martynyuk, A G Ovchinnikov, M B Stenina, O P Trophimova, F T Ageev   +11 more
doaj   +1 more source

Influence of shear rate and surface chemistry on thrombus formation in micro-crevice [PDF]

Journal of Biomechanics, Volume 121, 2021, 110397, ISSN 0021-9290, 2020
Thromboembolic complications remain a central issue in management of patients on mechanical circulatory support. Despite the best practices employed in design and manufacturing of modern ventricular assist devices, complexity and modular nature of these systems often introduces internal steps and crevices in the flow path which can serve as nidus for ...
arxiv   +1 more source

Direct Oral Anticoagulants (DOACs) are Non-Inferior to Vitamin K Antagonists for Patients Undergoing Transcatheter Aortic Valve Replacement with Indications of Anticoagulation

Reviews in Cardiovascular Medicine, 2022
Background: The best anticoagulation choice for patients undergoing transcatheter aortic valve replacement (TAVR) with indications of oral anticoagulation (OAC) remains uncertain.
Jia Wang, Feng-Ying Zhang, Li Liu, Mang-Mang Pan, Chi Zhang, Jin Chen, Yuan Bian, Hou-Wen Lin, Zhi-Chun Gu   +8 more
doaj   +1 more source

Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors

TH Open, 2022
Heparin has already been found in a variety of animal tissues but only few of them became effective sources for production of pharmaceutical preparations.
Stephan N.M.C.G. Oliveira, Ana M.F. Tovar, Francisco F. Bezerra, Adriana A. Piquet, Nina V. Capillé, Paloma S. Santos, Eduardo Vilanova, Paulo A.S. Mourão   +7 more
doaj   +1 more source

Balloon pulmonary angioplasty – efficient therapy of chronic thromboembolic pulmonary hypertension in the patient with advanced sarcoidosis – a case report

BMC Pulmonary Medicine, 2018
Background Approximately a quarter of patients with advanced sarcoidosis develop pulmonary hypertension (PH), which affects their prognosis. We report unusual case of confirmed chronic thromboembolic pulmonary hypertension (CTEPH) in a patient with stage
Andrzej Labyk, Dominik Wretowski, Sabina Zybińska-Oksiutowicz, Aleksandra Furdyna, Katarzyna Ciesielska, Dorota Piotrowska-Kownacka, Olga Dzikowska –Diduch, Barbara Lichodziejewska, Andrzej Biederman, Piotr Pruszczyk, Marek Roik   +10 more
doaj   +1 more source